Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vistagen Therapeutics (VTGN) Prepaid Assets (2016 - 2025)

Vistagen Therapeutics (VTGN) has disclosed Prepaid Assets for 14 consecutive years, with $1.5 million as the latest value for Q4 2025.

  • Quarterly Prepaid Assets rose 6.81% to $1.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.5 million through Dec 2025, up 6.81% year-over-year, with the annual reading at $1.6 million for FY2025, 5.84% up from the prior year.
  • Prepaid Assets hit $1.5 million in Q4 2025 for Vistagen Therapeutics, down from $1.8 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $3.5 million in Q2 2025 to a low of $802000.0 in Q1 2023.
  • Historically, Prepaid Assets has averaged $1.9 million across 5 years, with a median of $1.7 million in 2025.
  • Biggest five-year swings in Prepaid Assets: surged 487.4% in 2021 and later plummeted 70.79% in 2023.
  • Year by year, Prepaid Assets stood at $2.9 million in 2021, then crashed by 67.54% to $953200.0 in 2022, then soared by 55.3% to $1.5 million in 2023, then fell by 6.71% to $1.4 million in 2024, then rose by 6.81% to $1.5 million in 2025.
  • Business Quant data shows Prepaid Assets for VTGN at $1.5 million in Q4 2025, $1.8 million in Q3 2025, and $3.5 million in Q2 2025.